Literature DB >> 29488270

Evolution of diagnostic criteria and assessments for Parkinson's disease mild cognitive impairment.

Jennifer G Goldman1, Samantha K Holden2, Irene Litvan3, Ian McKeith4, Glenn T Stebbins1, John-Paul Taylor4.   

Abstract

Mild cognitive impairment has gained recognition as a construct and a potential prodromal stage to dementia in both Alzheimer's disease and Parkinson's disease (PD). Although mild cognitive impairment has been recognized in the Alzheimer's disease field, it is a relatively more recent topic of interest in PD. Recent advances include the development of diagnostic criteria for PD mild cognitive impairment to provide more uniform definitions for clinical and research use. Studies reveal that mild cognitive impairment in PD is frequent, but also heterogeneous, with variable clinical presentations, differences in its progression to dementia, and likely differences in underlying pathophysiology. Application of the International Parkinson and Movement Disorder Society PD Mild Cognitive Impairment Task Force diagnostic criteria has provided insights regarding cognitive measures, functional assessments, and other key topics that may require additional refinement. Furthermore, it is important to consider definitions of PD mild cognitive impairment in the landscape of other related Lewy body disorders, such as dementia with Lewy bodies, and in the context of prodromal and early-stage PD. This article examines the evolution of mild cognitive impairment in concept and definition, particularly in PD, but also in related disorders such as Alzheimer's disease and dementia with Lewy bodies; the development and application of International Parkinson and Movement Disorder Society PD Mild Cognitive Impairment diagnostic criteria; and insights and future directions for the field of PD mild cognitive impairment.
© 2018 International Parkinson and Movement Disorder Society. © 2018 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  biomarkers; dementia; diagnostic criteria; mild cognitive impairment; neuropsychological

Mesh:

Year:  2018        PMID: 29488270     DOI: 10.1002/mds.27323

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  18 in total

Review 1.  Predictors of cognitive impairment in Parkinson's disease: a systematic review and meta-analysis of prospective cohort studies.

Authors:  Yu Guo; Feng-Tao Liu; Xiao-He Hou; Jie-Qiong Li; Xi-Peng Cao; Lan Tan; Jian Wang; Jin-Tai Yu
Journal:  J Neurol       Date:  2020-03-12       Impact factor: 4.849

2.  Brain connectivity markers in advanced Parkinson's disease for predicting mild cognitive impairment.

Authors:  Hai Lin; Zesi Liu; Wei Yan; Doudou Zhang; Jiali Liu; Bin Xu; Weiping Li; Qiusheng Zhang; Xiaodong Cai
Journal:  Eur Radiol       Date:  2021-06-09       Impact factor: 5.315

3.  Capturing Subjective Mild Cognitive Decline in Parkinson's Disease.

Authors:  Sara Rosenblum; Sonya Meyer; Ariella Richardson; Sharon Hassin-Baer
Journal:  Brain Sci       Date:  2022-06-05

4.  REM Sleep Behavior Disorder in Parkinson's Disease: Effects on Cognitive, Psychiatric, and Functional outcomes.

Authors:  Zanjbeel Mahmood; Ryan Van Patten; Marina Z Nakhla; Elizabeth W Twamley; J Vincent Filoteo; Dawn M Schiehser
Journal:  J Int Neuropsychol Soc       Date:  2020-05-07       Impact factor: 2.892

5.  Direct and indirect assessment of functional abilities in patients with Parkinson's disease transitioning to dementia.

Authors:  Gisele Saraiva Reis de Oliveira; Lúcia Bressan; Fernanda Balarini; Raquel Silveira Jesuino E Silva; Manuelina Mariana Capellari Macruz Brito; Maria Paula Foss; Bruno Lopes Santos-Lobato; Vitor Tumas
Journal:  Dement Neuropsychol       Date:  2020 Apr-Jun

6.  Altered Functional Interactions of Inhibition Regions in Cognitively Normal Parkinson's Disease.

Authors:  Deborah L Harrington; Qian Shen; Rebecca J Theilmann; Gabriel N Castillo; Irene Litvan; J Vincent Filoteo; Mingxiong Huang; Roland R Lee
Journal:  Front Aging Neurosci       Date:  2018-10-23       Impact factor: 5.750

Review 7.  Correlations of Neuropsychological and Metabolic Brain Changes in Parkinson's Disease and Other α-Synucleinopathies.

Authors:  Maja Trošt; Matej Perovnik; Zvezdan Pirtošek
Journal:  Front Neurol       Date:  2019-11-14       Impact factor: 4.003

8.  Beyond PD-MCI: objectively defined subtle cognitive decline predicts future cognitive and functional changes.

Authors:  Jacob D Jones; Carmen Uribe; Joseph Bunch; Kelsey R Thomas
Journal:  J Neurol       Date:  2020-08-17       Impact factor: 4.849

9.  Measuring executive dysfunction in Parkinson's disease: Reliability and validity of the Spanish version of Frontal Assessment Battery (FAB-E).

Authors:  Miriam Hurtado-Pomares; María Carmen Terol-Cantero; Alicia Sánchez-Pérez; Carlos Leiva-Santana; Paula Peral-Gómez; Desirée Valera-Gran; Eva María Navarrete-Muñoz
Journal:  PLoS One       Date:  2018-11-19       Impact factor: 3.240

Review 10.  Cognition Deficits in Parkinson's Disease: Mechanisms and Treatment.

Authors:  Congcong Fang; Longqin Lv; Shanping Mao; Huimin Dong; Baohui Liu
Journal:  Parkinsons Dis       Date:  2020-03-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.